Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -52.3% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 13.4 | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.4 | n/a |
Pr/Book | 0.5 |
Latest | F'cast | |
---|---|---|
Revenue | -37.5% | n/a |
PBT | n/a | n/a |
EPS | -54.3% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 432.60 | (311.40) | (175.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 418.50 | (245.10) | (144.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 523.50 | (70.70) | (42.20)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 648.90 | 30.50 | 13.80p | 2.7 | n/a | n/a | n/a | 0.0% |
31-Dec-24 | 405.30 | (212.10) | 6.30p | 15.0 | n/a | -54% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Total Voting Rights | 01-Apr-2025 | 15:01 | EQS Group |
Director/PDMR Shareholding | 01-Apr-2025 | 13:10 | EQS Group |
Publication of Offering Circular relating to the... | 24-Mar-2025 | 15:25 | EQS Group |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
31-Mar-25 | Buy | Nick Winsor | 89.99p | 100,000 | £89,987.61 |
10-Mar-25 | Buy | Paul Coby | 86.90p | 22,480 | £19,535.12 |
03-Mar-25 | Buy | Marc Page | 81.88p | 31,266 | £25,599.66 |
Currency | UK Pounds |
Share Price | 78.80p |
Change Today | -5.70p |
% Change | -6.75 % |
52 Week High | 107.00 |
52 Week Low | 30.55 |
Volume | 970,695 |
Shares Issued | 673.00m |
Market Cap | £530.33m |
Beta | 0.00 |
RiskGrade | 336 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:30 | 366 @ 78.50p |
10:38 | 31 @ 79.00p |
09:12 | 97 @ 78.00p |
10:31 | 31 @ 79.00p |
10:30 | 13 @ 79.00p |
CEO | Daniel Frumkin |
Chair | Robert Sharpe |
CFO | Marc Page |
You are here: research